Who are Indocyanine Green Drug's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): ICG R15.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/indocyanine-green-drug.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Indocyanine Green Drug — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Indocyanine Green Drug (Indocyanine Green Drug) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Near-infrared fluorescent contrast agent. Area: Diagnostic imaging / Surgery.

marketed Near-infrared fluorescent contrast agent Diagnostic imaging / Surgery Small molecule Live · refreshed every 30 min

Target snapshot

Indocyanine Green Drug (Indocyanine Green Drug) — Theodor Bilharz Research Institute. Indocyanine Green is a near-infrared fluorescent dye that absorbs and emits light in the near-infrared spectrum for diagnostic imaging and surgical visualization.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Indocyanine Green Drug TARGET	Indocyanine Green Drug	Theodor Bilharz Research Institute	marketed	Near-infrared fluorescent contrast agent
ICG R15	ICG R15	Seoul National University Hospital	marketed	Near-infrared fluorescent contrast agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Near-infrared fluorescent contrast agent class)

Seoul National University Hospital · 1 drug in this class
Theodor Bilharz Research Institute · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Indocyanine Green Drug — Competitive Intelligence Brief. https://druglandscape.com/ci/indocyanine-green-drug. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab